Correction: A Survey of Availability and Affordability of Polypills for Cardiovascular Disease in Selected Countries
Gautam Satheesh, Bishal Gyawali, Marie France Chan Sun, Mark D. Huffman, Amitava Banerjee, Pablo Perel, Adrianna Murphy
TL;DR
This paper corrects a previously published survey on the availability and affordability of polypills for cardiovascular disease in several countries.
Contribution
The paper provides a correction to a prior study, ensuring accuracy in the survey's findings and references.
Findings
The original survey findings on polypill availability and affordability remain unchanged.
The correction addresses errors in the original publication's references and formatting.
No new data was collected; the correction focuses on improving the integrity of the published work.
Abstract
This article details a correction to: Satheesh, G., Gyawali, B., Sun, M.F.C., Huffman, M.D., Banerjee, A., Perel, P. and Murphy, A. (2024) ‘A Survey of Availability and Affordability of Polypills for Cardiovascular Disease in Selected Countries’. Global Heart. 19(1):p. 56. Available at: https://doi.org/10.5334/gh.1335.
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsMedication Adherence and Compliance · Pharmaceutical Economics and Policy
Correction
The initially published version of the article indicated that “The concept of combining antihypertensives with statins and aspirin for the secondary prevention of CVD was first introduced by the World Health Organization (WHO) in 2001”. In fact, the concept was proposed in 2000 in patents GB 0100548.7 and GB 008791.6 filed by Malcolm Law and Nicholas Wald and discussed in 2001 by a group of experts from WHO and the Wellcome Trust.
The reference list from the paper itself. Each links out to its DOI / PubMed record.
- 1Satheesh G, Gyawali B, Sun MFC, Huffman MD, Banerjee A, Perel P, Murphy A. ‘A Survey of Availability and Affordability of Polypills for Cardiovascular Disease in Selected Countries’. Global Heart. 2024; 19(1):p. 56. doi:10.5334/gh.133538973984 PMC 11225556 · doi ↗ · pubmed ↗
- 2Wald NJ, Law MR. Formulation for the Prevention of Cardiovascular Disease. UK Patents GB 008791 and GB 0100548; 2000.
- 3World Health Organization. Secondary prevention of non-communicable disease in low and middle income countries through community-based and health service interventions. Geneva. 2002; 1–3 August.